newsfilter
← Latest News
PR Newswire·

Synaptogenix Announces Plan to Uplist on the Nasdaq Stock Market

NEW YORK, May 19, 2021 /PRNewswire/ -- Synaptogenix, Inc. (OTC:SNPX), an emerging biopharmaceutical company focused on developing therapies for neurodegenerative diseases, announced that the Company's Board of Directors has approved a one-for-four reve